I-Mab announced positive results from a Phase 1b study of its bispecific antibody, givastomig, which targets Claudin 18.2 and 4-1BB for treating Claudin 18.2-positive gastric cancers. The study, ...

Initial data from ongoing Phase 1/2 trial in patients with second and third line PDAC treated with vopimetostat and daraxonrasib showed 6-month ...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced updated data from Part A of the ...

Qaelon Medical and Scialytics today announced a strategic, non-exclusive partnership to integrate Qaelon's real-time physiologic GI data into Scialytics' AI-driven surgical analytics platform. The ...

The world has come to appreciate the importance of data providing hard evidence of what happens over time. Today, data plays a crucial role across nearly every industry. Data analysis has become a ...

Please provide your email address to receive an email when new articles are posted on . Subjective cough measures have downfalls that objective cough monitors can address. Cough monitoring tool ...

In the pursuit of recognizing true talent, industries often face a critical question: How can one accurately measure ability and potential? Over time, traditional subjective assessments have shown ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, is partnering with industry leader Masimo (NASDAQ: MASI) to bring best-in-class ...

In today's fast-paced and increasingly digital business environment, data has become the lifeblood of companies; it drives growth, innovation and competitive advantage. The question is not whether ...